IF WE monitor real time blood pressure can we save lives from hypertension?

WHAT CHALLENGE DOES DYNOCARDIA ADDRESS ?

There is an unmet need for accurate and continuous non-invasive blood pressure (cNIBP) monitoring. Problems stemming from inaccurate, intermittent (single-time-point) BP measurement and sub-therapeutic management of BP are particularly pronounced in hospitals, where currently, the only option for continuous measurement is the invasive intra-arterial catheter, which can lead to clinically significant complications. The other option, cuffed devices, provide only intermittent and often inaccurate BP readings.

Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrack™, lead diagnostic device, is powered their proprietary technology making it the only stand-alone, cuff-less device that allows for continuous blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines.

DISCOVER DYNOCARDIA’S BREAKTHROUGH INNOVATION

The first standalone cuffless, wearable technology to measure BP accurately and continuously.

Dynocardia’s proprietary ViTrack™ methodology is the technology behind ViTrack, a wrist- wearable device with the processing power to enable continuous beat-to-beat BP monitoring. ViTrack technology is poised to surmount century-old obstacles to obtaining accurate and continuous measurement of BP by enabling ambulatory and nocturnal measurement. Additionally, ViTrack technology holds great promise for improving outcomes in 1.5 billion people living with hypertension around the world, who are at heightened risk for stroke and heart attacks.

HOW DOES THE 3DEXPERIENCE LAB HELP DYNOCARDIA ?

“We are so grateful to 3DS for their interest in our work and investment in our efforts” says Dynocardia founder Mohan Thanikachalam, MD. We believe that their state-of-the-art prototyping facilities located here in Boston, along with 3DS’s product-development-software portfolio, automated platform for clinical trial recruitment, and strength of their engineering, IT, and design teams worldwide will allow us to commercialize ViTrack™ much faster than we’d have been able to otherwise.

DYNOCARDIA’S SUSTAINABLE DEVELOPMENT GOALS 🌍

Dynocardia joined the 3DEXPERIENCE Lab in 2020

KEY FACTS